Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05915910 · ClinicalTrials.gov registry record
Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease Type 1B (GSD1b)
A clinical trial, sponsored by Sanguine Biosciences.
- Terminated
- Registry status
- 6
- Enrollment target
NCT05915910: Clinical Trial study, sponsored by Sanguine Biosciences.
NCT05915910 is a clinical trial that was terminated before completion, run by Sanguine Biosciences. The registered enrollment target is 6 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05915910 was terminated before completion, sponsored by Sanguine Biosciences.
- TERMINATED
- Registry status
- 6 participants
- Enrollment target
Study Summary
The primary objective of this study is to collect whole blood from patients diagnosed with Glycogen storage disease type 1B, which will be used to support the investigation of potential therapies that address the genetic basis of this disease.
Primary Outcome
Bipspecimen collection from subjects or their parental guardians that are diagnosed with Glycogen Storage Disease Type Ib(GSD1b, von Gierke disease) for the purpose to analyze the biospecimens to support the investigation of potential therapies that address the genetic basis of this disease. The primary outcome measure is the collection of biospecimens for quantitative analysis using PBMC processes to report cell viability of at least 5M cells per vial.
Interventions
- DIAGNOSTIC_TEST Specimen Donation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2023-04-27 |
| Est. Completion | 2024-03-13 |
Why NCT05915910 stopped before completion
NCT05915910 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Specimen Donation is the first listed.
NCT05915910 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05915910 about?
NCT05915910 is a clinical study titled "Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease Type 1B (GSD1b)". The primary objective of this study is to collect whole blood from patients diagnosed with Glycogen storage disease type 1B, which will be used to support the investigation of potential therapies that address the genetic basis of this disease.
What is the current status of trial NCT05915910?
This trial is currently terminated. The enrollment target is 6 participants. The study started on 2023-04-27. Estimated completion is 2024-03-13.
What interventions are being tested in trial NCT05915910?
The interventions under investigation include: Specimen Donation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05915910?
This trial is sponsored by Sanguine Biosciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI